In last trading session, Conduit Pharmaceuticals Inc (NASDAQ:CDT) saw 0.51 million shares changing hands with its beta currently measuring 2.16. Company’s recent per share price level of $1.09 trading at $0.08 or 7.92% at ring of the bell on the day assigns it a market valuation of $5.13M. That closing price of CDT’s stock is at a discount of -35863.3% from its 52-week high price of $392.00 and is indicating a premium of 10.09% from its 52-week low price of $0.98. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.85 million shares which gives us an average trading volume of 3.76 million if we extend that period to 3-months.
Conduit Pharmaceuticals Inc (NASDAQ:CDT) trade information
Upright in the green during last session for gaining 7.92%, in the last five days CDT remained trading in the red while hitting it’s week-highest on Tuesday, 03/11/25 when the stock touched $1.09 price level, adding 7.63% to its value on the day. Conduit Pharmaceuticals Inc’s shares saw a change of -84.11% in year-to-date performance and have moved -0.91% in past 5-day. Conduit Pharmaceuticals Inc (NASDAQ:CDT) showed a performance of -38.76% in past 30-days. Number of shares sold short was 0.45 million shares which calculate 0.06 days to cover the short interests.
Conduit Pharmaceuticals Inc (NASDAQ:CDT)’s Major holders
Insiders are in possession of 13.92% of company’s total shares while institution are holding 2.41 percent of that, with stock having share float percentage of 2.80%. Investors also watch the number of corporate investors in a company very closely, which is 2.41% institutions for Conduit Pharmaceuticals Inc that are currently holding shares of the company.
On the other hand, Fidelity Small Cap Index Fund and Vanguard Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024 , the former fund manager was holding 4.03 shares of worth $4397.0 or 0.11% of the total outstanding shares. The later fund manager was in possession of 2.03 shares on Dec 31, 2024 , making its stake of worth around $2211.0 in the company or a holder of 0.06% of company’s stock.
